Fig. 3From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effectsMMP-2 levels before and after treatment in both groups. There is no difference in the MMP-2 levels between the two groups before treatment, but the IL-12 levels decrease markedly after treatment, and the MMP-2 levels in group B are lower than that in group A (p<0.05). Note: *p<0.05Back to article page